Blog – where we showcase some physical phenomena in microfluidics

1. Cell sorting in microfluidics (via DLD)


Microfluidic devices have been used to separate a variety of target cells and particles from samples like blood, urine or cerebral spinal fluid.

One approach to this separation uses an impressive, passive microfluidic technique called deterministic lateral displacement (DLD for short). The beauty lies in its simplicity: Once you have built your array, the sorting is basically a by-product of the sample flowing through the device. Your perfectly tailored microfluidic environment can run continuously, separating your desired targets (e.g. circulating tumour cells, parasites, marker DNA, exosomes, etc.…) from anything else in your sample.

So, why is it not widely used?

Well, it is not that simple (of course!)

Naive model

First of all, even the simplified „naive model“ (as Timm Krueger and I love to call it) takes a bit time to think through there:

The figure above illustrates the top view of a typical deterministic lateral displacement (DLD) geometry. Rightmost panel shows geometric details. G is the gap size, λ is the pillar array pitch (here, identical for x and y directions), D is the post diameter, and Δλ is the row shift. The row shift fraction in this example is ε=Δλ/λ= 1/4, and the tilt angle is α= tan−1(ε). The shifted post arrangement separates the fluid flow into distinct flow lanes (shown in different shadings) separated by a periodic pattern of stagnation streamlines (centre panel). The leftmost panel shows these flow lanes (N=1/ε= 4, here) through a single gap. The width of the “first”(pillar adjacent) flow lane β through each pillar gap gives a first-order approximation of the critical separation radius. Pic and text reproduced from [1]:

So, basically, your sample flows through an array, that is tilted in respect to the main flow. The smaller the tilt, the more lanes your flow is divided into. The more lanes, the smaller is each lane – especially around a post of the array. Now, if your particle is significantly bigger than the lane it travels in, it gets pushed into another layer and cannot follow the flow anymore. In this picture, it gets bumped to the right (spoiler: look at the last picture of this post. There a parasite gets bumped downward, while blood cells can continue to flow along horizontally).

Plethora of parameters

Secondly, there is a number of parameters that influence the DLD performance:

Overview of parameters influencing the performance of deterministic lateral displacement (DLD), a powerful microfluidic technique. Reprinted from [1]:
A simplified overview of these interdependent parameters are shown in the causal loop diagram above: only the most common and important factors are included. For many applications, additional factors (like sample biochemistry, or sample viscosity) also play a role. Interrelations are shown as arrows. Arrows with a green plus (+) sign indicate that an increase (or decrease) in the upstream factor causes an increase (or decrease) in the downstream one. Arrows with a red minus (−) sign indicate that increasing (or reducing) the upstream factor reduces (or increases) the downstream one. Arrows without signs indicate a complex or unclear relation between factors. Factors are divided into four groups: (1) device geometry, (2) device material, (3)sample/particle properties, and (4)flow/operational properties (colours are used solely for classification). Clogging plays a special role because it is affected by various factors. The central circle labelled “DLD” stands for all desired outcomes of the application (e.g., separation efficiency,critical size). Images and text are based on [1]:

BUT: Although it is complicated, it is not impossible:

Above, you see a DLD device separating red blood cells (red) from a trypanosome (blue) simply based on shape and size. No electricity needed. The flow of the sample through the device is all that is needed.

If this sounds intriguing, and you wonder whether DLD is right for you, contact us!

We will get you sorted!

2. Microfluidics for drug discovery and 3R

Microfluidics has many applications. One of these is surprisingly under-used – despite the potential to save billions of Euros and years of research time, and to save thousands of (animal) lives: Organs-on-a-Chip (OoaC)

OoaC are miniaturized models of (human) organs. They are kept in a highly controllable, microfluidic environment.

Since they have the full functionality of organs, they can be used in drug development (metabolizing drugs, screening for cytotoxic drugs and metabolites). Simultaneously, their massively smaller size and independence from other organs makes them cheaper to grow and culture, and reduces the amount of nutrients and drugs needed.

For pharmaceutical companies, OoaC is the clever step to take:

Out of 10 potential drug /target molecules that are successful in cell culture and mouse model test, 9 fail in human testing, having cost around 2.5 Billion $ and 10-12 years. Why do 90% fail? Because of the differences between mice and men.

Here, human Organs-on-a-Chip can help! With a setup running in parallel or even before the animal models, these 9 out of 10 duds can be screened out, saving billions of Euros or Dollars and years of time, allowing us to focus on the 1 candidate, that will also actually work in humans.

Balancing these billions of Euros with the initial costs to use OoaC (which is between tens of thousands to a few millions) it is surprising that so few have done it!

But how would an Organ-o-a-Chip look like?

Let’s illustrate that with a potential drug that needs to

  • A) cross the blood-brain barrier (or any other kind of tissue: lung tissue, epidermis…) and
  • B) affect a certain kind of pathogen there

This can be done in the following sample device:

Figure 1: A simplified scheme for an Organ-on-a-Chip that uses a blood-brain barrier* separating pathogens from a “blood stream” below.

This device is made of two halves (top and bottom) separated by the tissue we want to culture inside. The cells are growing on a support layer, that can also supply the cells with medium and wash away metabolites. The top layer however would be, where the evil pathogens abide.

The cells are grown in a confluent blood-brain barrier* and keep the pathogens at bay.

Now, we can inject the drug candidates into the support layer, and see

  • A) whether the pathogens will be eliminated
  • B) how fast this happens
  • C) whether the cells themselves take any damage.

*: It should be noted that this is a simplified scheme. Making a functional blood-brain barrier already requires co-culture of more than one cell type. The details on how to grow these cells, and how to feed the inlets and take away the waste would be way too much for here. But if you are interested, contact us at, and we will get you started on the process. Promised!

This is, as mentioned, still a rather simple and straightforward example for an Organ-on-a-Chip.

Of course, one can have several organs in a row, to study the interplay of drugs and metabolites or infections. There are several companies currently working with two or three interconnected organs on one chip. One can even grow an entire „Human-on-a-Chip“ to see the full metabolism (e.g., lung – gut – liver – heart – bone marrow – kidney, see Figure 2) of a drug.

Figure 2: Simplified Scheme of interconnected Organs-on-a-Chip to investigate the entire metabolism of a drug. Source:

But for most applications, that is going too far, and a simpler approach can already yield very good results. This means, with even just 2 or 3 OoaC you can screen off 7-9 of the 10 candidates that work in mice, but not in humans. Of course, there are challenges: co-culturing of different cell lines with their own nutrition and growth requirements, handling of several fluid streams, etc…

But in general, here are the Pros and Cons one should consider:

Potential to screen out ineffective candidates before they reach animal or human trialsInitial investment necessary
No animals (license) neededIn-depth knowledge needed to set up the lab equipment and train staff (this can be outsourced to „Life on a Chip“ though; )
Possibility to use actual human cell lines for human targeted products
Smaller sample volumes needed
Faster results
High concentration control
Saves money and time
Possibility to assess different cell lines (human / mouse/ rat/ rabbit) in parallel

Some of the often overlooked features of Organs on a Chip are

  • it is possible to use several organs in sequence
  • it is possible to grow targeted inflamed/damaged/infected organs – and study the polyomics of that
  • it is compliant with 3R and thus makes your project eligible for funding
  • it is an additional trial phase that can screen out ineffective drug candidates prior to animal or human trials.

If you have any questions, simply contact us.